Introduction: This work is focused on the study of the inhibition activity exerted by some donepezil derivatives, on the acetlycholinesterase and b-secretase 1 (Bace-1) activities, potentially useful as dual inhibitors for the treatment of Alzheimer’s disease (AD). Results: The Authors report the effect produced by some donepezil derivatives on the enzymatic activity of acetlycholinesterase and Bace-1. Conclusion: In vitro AChE activity inhibition represent an useful approach to identity molecular candidates for a more appropriate AD therapy.
DONEPEZIL DERIVATIVES AS DUAL ACETYLCHOLINESTERASE AND b-SECRETASE 1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE
Ascione Antonio
2020-01-01
Abstract
Introduction: This work is focused on the study of the inhibition activity exerted by some donepezil derivatives, on the acetlycholinesterase and b-secretase 1 (Bace-1) activities, potentially useful as dual inhibitors for the treatment of Alzheimer’s disease (AD). Results: The Authors report the effect produced by some donepezil derivatives on the enzymatic activity of acetlycholinesterase and Bace-1. Conclusion: In vitro AChE activity inhibition represent an useful approach to identity molecular candidates for a more appropriate AD therapy.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
ACTA 2-2020 - NASSO, ASCIONE.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
710.43 kB
Formato
Adobe PDF
|
710.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.